BiotechTube

BOTOX + Placebo for BOTOX

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Upper Limb Essential Tremor (UL ET)

Conditions

Upper Limb Essential Tremor (UL ET)

Trial Timeline

Apr 12, 2022 → Feb 3, 2025

NCT ID
NCT05216250

About BOTOX + Placebo for BOTOX

BOTOX + Placebo for BOTOX is a phase 2 stage product being developed by AbbVie for Upper Limb Essential Tremor (UL ET). The current trial status is completed. This product is registered under clinical trial identifier NCT05216250. Target conditions include Upper Limb Essential Tremor (UL ET).

What happened to similar drugs?

6 of 15 similar drugs in Upper Limb Essential Tremor (UL ET) were approved

Approved (6) Terminated (1) Active (9)
✅Remimazolam TosilateJiangsu Hengrui MedicineApproved
✅BOTOXAbbVieApproved
✅Montelukast + PlaceboMerckApproved
🔄Muntelukast + PlaceboMerckPhase 3
🔄IFF flavor 316 282, Paracetamol, PseudoephedrineNovartisPhase 3
🔄Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets + Paracetamol (500 mg) tabletsNovartisPhase 3
✅diclofenac potassium + nimesulideNovartisApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT06137287Phase 3Completed
NCT05216250Phase 2Completed
NCT05141006Phase 2Completed

Competing Products

20 competing products in Upper Limb Essential Tremor (UL ET)

See all competitors
ProductCompanyStageHype Score
Nivolumab 100 MG in 10 ML InjectionOno PharmaceuticalPhase 2
31
Remimazolam TosilateJiangsu Hengrui MedicineApproved
43
ABBV-950 + BOTOX + Placebo for ABBV-950AbbViePhase 1
21
BOTOXAbbVieApproved
43
MK-3475 and BCGMerckPhase 2
42
Montelukast + PlaceboMerckApproved
43
Muntelukast + PlaceboMerckPhase 3
36
IFF flavor 316 282, Paracetamol, PseudoephedrineNovartisPhase 3
40
Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets + Paracetamol (500 mg) tabletsNovartisPhase 3
40
diclofenac potassium + nimesulideNovartisApproved
35
Diclofenac gelNovartisApproved
43
IFF flavor 316 282, Paracetamol , Phenylephrine, GuaifenesinNovartisPhase 3
40
Domvanalimab + Zimberelimab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin + NivolumabGilead SciencesPhase 3
44
Azithromycin SRPfizerPhase 3
40
NivolumabBristol Myers SquibbPre-clinical
26
NivolumabBristol Myers SquibbPre-clinical
26
REGN475/SAR164877 + Placebo (for REGN475/SAR164877)Regeneron PharmaceuticalsPhase 2
27
IPN10200 + IPN10200 Placebo + DysportIpsenPhase 1/2
36
AboBoNT-A + OnaBoNT-AIpsenApproved
40
Botulinum toxin type AIpsenPhase 3
37